Skip to main content

Advertisement

Log in

A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric Cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The goals of this study were to assess the feasibility and toxicity of a regimen of preoperative chemoradiotherapy, surgery, and intraoperative radiotherapy in the treatment of patients with potentially resectable gastric cancer. A secondary objective was to assess pathologic response to chemoradiotherapy in the treated tumors.

Methods: Twenty-four patients were entered in the protocol. Treatment regimen consisted of 45 Gy of external beam radiotherapy with concurrent 5-FU given as a continuous infusion at a dose of 300 mg/m2. Patients were restaged 4–6 weeks after chemoradiotherapy and then underwent surgical resection and intraoperative radiotherapy to a dose of 10 Gy.

Results: Twenty-three patients (96%) completed chemoradiotherapy in accordance with the study protocol. Nineteen (83%) of 23 patients who completed chemoradiotherapy underwent surgical resection with D2 lymphadenectomy. Four patients (17%) had progressive disease and were not resected. The morbidity and mortality rates were 32% and 5%, respectively. Of the resected patients, two (11%) had complete pathologic responses while 12 (63%) had pathologic evidence of significant treatment effect.

Conclusions: Preoperative chemoradiotherapy for gastric cancer can be delivered safely and is well tolerated. The rate of surgical complications is consistent with that of other recently reported prospective trials of gastrectomy alone. Preoperative chemoradiotherapy resulted in significant pathologic responses in the majority of treated tumors, and complete pathologic responses were achieved in some patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1999. CA Cancer J Clin 2000; 49: 8–31.

    Google Scholar 

  2. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583–92.

    Google Scholar 

  3. Gunderson LG, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982; 8: 1–11.

    Google Scholar 

  4. Landry J, Tepper JE, Wood WC, et al. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990; 19: 1357–62.

    Google Scholar 

  5. McNeer G, Vanderberg H, Donn FY, et al. A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 1951; 134: 2–7.

    Google Scholar 

  6. Sindelar WF, Kinsella TJ, Tepper JE, et al. Randomized trial of intraoperative radiotherapy in carcinoma of the stomach. Am J Surg 1993; 165: 178–87.

    Google Scholar 

  7. Guzel Z, Gajl D, Grzegorzewski J. Postoperative radiotherapy in gastric cancer. J Surg Oncol 1995; 58: 35–9.

    Google Scholar 

  8. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 1981; 7: 863–8.

    Google Scholar 

  9. Calvo FA, Henriquez I, Santos M, et al. Intraoperative and external beam radiotherapy in advanced resectable gastric cancer: technical description and preliminary results. Int J Radiat Oncol Biol Phys 1989; 17: 183–9.

    Google Scholar 

  10. Avizonis VN, Buzydlowski J, Lanciano R, et al. Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a Phase II study from Radiation Therapy Oncology Group 85–04. Ann Surg Oncol 1995; 2: 295–302.

    Google Scholar 

  11. Gilly FN, Gerarad JP, Braillon G, et al. Intraoperative radiotherapy in gastric adenocarcinomas. Report of 45 cases. Ann Chir 1993; 47: 234–9.

    Google Scholar 

  12. Minsky BD. Multidisciplinary management of resectable rectal cancer. Oncology 1996; 10: 1701–14.

    Google Scholar 

  13. Ajani JA. Current status of new drugs and multidisciplinary management approaches in patients with carcinoma of the esophagus. Chest 1998; 113: 112S–9S.

    Google Scholar 

  14. Allum WH, Hallissey MT, Ward LC, et al. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. Br J Cancer 1989; 60: 739–44.

    Google Scholar 

  15. Shimosato Y, Oboshi S, Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1971; 1: 19–35.

    Google Scholar 

  16. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992; 127: 1335–9.

    CAS  PubMed  Google Scholar 

  17. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462–7.

    Article  CAS  PubMed  Google Scholar 

  18. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995; 32: 1025–9.

    Google Scholar 

  19. Evans DB, Abbruzzese JL, Cleary KR, et al. Rapid-fractionation pre-operative chemoradiation for periampullary neoplasms. J R Coll Surg Edinb 1995; 40: 319–23.

    Google Scholar 

  20. Coia L, Hoffman J, Scher R, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 1994; 30: 161–7.

    Google Scholar 

  21. Cushieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347: 995–9.

    Article  Google Scholar 

  22. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745–8.

    Article  CAS  PubMed  Google Scholar 

  23. MacDonald JS, Smalley S, Benedetti J, et al. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Proc Am Soc Clin Oncol 2000; 19: 1a.

    Google Scholar 

  24. Songun I, Keizer HJ, Hermans J, et al. Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer 1999; 35: 558–62.

    Google Scholar 

  25. Lowy AM, Mansfield PF, Leach SD, et al. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999; 229: 303–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul F. Mansfield MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lowy, A.M., Feig, B.W., Janjan, N. et al. A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric Cancer. Ann Surg Oncol 8, 519–524 (2001). https://doi.org/10.1007/s10434-001-0519-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0519-1

Key Words

Navigation